Physician profile
Paige E Morris
NPI 1740240399
$743.06
in general payments reported to CMS, 2019-2025
11 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $75.00 · 2022: $140 · 2024: $28.73 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $178.59 | 2025 | Blueprint Patient Specific Instrumentation |
| Astrazeneca Pharmaceuticals LP | $114.94 | 2022 | |
| Lilly USA, LLC | $95.75 | 2025 | Mounjaro, Zepbound |
| Genentech USA, INC. | $87.04 | 2019 | |
| Janssen Biotech, INC. | $84.95 | 2019 | |
| Amgen INC. | $53.09 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $32.38 | 2019 | |
| Exact Sciences Corporation | $28.73 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.48 | 2022 | |
| Horizon Therapeutics Plc | $23.44 | 2020 | |
| Daiichi Sankyo INC. | $18.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.